Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Most Excellent results!

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison May 10, 2023 8:30pm

188 Views

Post# 35442126

RE:RE:RE:RE:RE:RE:Most Excellent results!

Gooseybear, we are lucky to have you here as a person going through a non-ending cycle of BCG treatments. If you have or have not discussed with your patient peers the possibility of migrating to Theralase's treatment, what percentage would you say 0% to 100%, thanks for your thoughts. Also you probably have had a conversation with your Oncologists and what has he/she said.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments